Medical Care
Global Autoimmune Therapeutics Drugs Market Research Report 2025
- Jul 08, 25
- ID: 349078
- Pages: 85
- Figures: 88
- Views: 54
The global market for Autoimmune Therapeutics Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Therapeutics Drugs.
The Autoimmune Therapeutics Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autoimmune Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Amgen
Novartis
Eli Lilly and Company
Pfizer
Roche Holding AG
AstraZeneca
Abbott Laboratories
Genentech
Merck & Co.
Bayer
Biogen
GlaxoSmithKline
Perrigo
Segment by Type
NSAIDs
Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs
Monoclonal Antibodies
Segment by Application
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Therapeutics Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Therapeutics Drugs.
The Autoimmune Therapeutics Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Autoimmune Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Therapeutics Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie
Amgen
Novartis
Eli Lilly and Company
Pfizer
Roche Holding AG
AstraZeneca
Abbott Laboratories
Genentech
Merck & Co.
Bayer
Biogen
GlaxoSmithKline
Perrigo
Segment by Type
NSAIDs
Corticosteroids
Disease-Modifying Anti-Rheumatic Drugs
Monoclonal Antibodies
Segment by Application
Hospitals and Clinics
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Therapeutics Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.2.4 Disease-Modifying Anti-Rheumatic Drugs
1.2.5 Monoclonal Antibodies
1.3 Market by Application
1.3.1 Global Autoimmune Therapeutics Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Therapeutics Drugs Market Perspective (2020-2031)
2.2 Global Autoimmune Therapeutics Drugs Growth Trends by Region
2.2.1 Global Autoimmune Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Autoimmune Therapeutics Drugs Historic Market Size by Region (2020-2025)
2.2.3 Autoimmune Therapeutics Drugs Forecasted Market Size by Region (2026-2031)
2.3 Autoimmune Therapeutics Drugs Market Dynamics
2.3.1 Autoimmune Therapeutics Drugs Industry Trends
2.3.2 Autoimmune Therapeutics Drugs Market Drivers
2.3.3 Autoimmune Therapeutics Drugs Market Challenges
2.3.4 Autoimmune Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Therapeutics Drugs Players by Revenue
3.1.1 Global Top Autoimmune Therapeutics Drugs Players by Revenue (2020-2025)
3.1.2 Global Autoimmune Therapeutics Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Autoimmune Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Autoimmune Therapeutics Drugs Revenue
3.4 Global Autoimmune Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Autoimmune Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Therapeutics Drugs Revenue in 2024
3.5 Global Key Players of Autoimmune Therapeutics Drugs Head office and Area Served
3.6 Global Key Players of Autoimmune Therapeutics Drugs, Product and Application
3.7 Global Key Players of Autoimmune Therapeutics Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Therapeutics Drugs Breakdown Data by Type
4.1 Global Autoimmune Therapeutics Drugs Historic Market Size by Type (2020-2025)
4.2 Global Autoimmune Therapeutics Drugs Forecasted Market Size by Type (2026-2031)
5 Autoimmune Therapeutics Drugs Breakdown Data by Application
5.1 Global Autoimmune Therapeutics Drugs Historic Market Size by Application (2020-2025)
5.2 Global Autoimmune Therapeutics Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Autoimmune Therapeutics Drugs Market Size (2020-2031)
6.2 North America Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)
6.4 North America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Therapeutics Drugs Market Size (2020-2031)
7.2 Europe Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)
7.4 Europe Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Therapeutics Drugs Market Size (2020-2031)
8.2 Asia-Pacific Autoimmune Therapeutics Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autoimmune Therapeutics Drugs Market Size (2020-2031)
9.2 Latin America Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)
9.4 Latin America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Therapeutics Drugs Market Size (2020-2031)
10.2 Middle East & Africa Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Autoimmune Therapeutics Drugs Introduction
11.1.4 AbbVie Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Autoimmune Therapeutics Drugs Introduction
11.2.4 Amgen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Autoimmune Therapeutics Drugs Introduction
11.3.4 Novartis Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Autoimmune Therapeutics Drugs Introduction
11.4.4 Eli Lilly and Company Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.4.5 Eli Lilly and Company Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Autoimmune Therapeutics Drugs Introduction
11.5.4 Pfizer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Roche Holding AG
11.6.1 Roche Holding AG Company Details
11.6.2 Roche Holding AG Business Overview
11.6.3 Roche Holding AG Autoimmune Therapeutics Drugs Introduction
11.6.4 Roche Holding AG Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.6.5 Roche Holding AG Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Autoimmune Therapeutics Drugs Introduction
11.7.4 AstraZeneca Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Autoimmune Therapeutics Drugs Introduction
11.8.4 Abbott Laboratories Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.8.5 Abbott Laboratories Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Autoimmune Therapeutics Drugs Introduction
11.9.4 Genentech Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.9.5 Genentech Recent Development
11.10 Merck & Co.
11.10.1 Merck & Co. Company Details
11.10.2 Merck & Co. Business Overview
11.10.3 Merck & Co. Autoimmune Therapeutics Drugs Introduction
11.10.4 Merck & Co. Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.10.5 Merck & Co. Recent Development
11.11 Bayer
11.11.1 Bayer Company Details
11.11.2 Bayer Business Overview
11.11.3 Bayer Autoimmune Therapeutics Drugs Introduction
11.11.4 Bayer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.11.5 Bayer Recent Development
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Autoimmune Therapeutics Drugs Introduction
11.12.4 Biogen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.12.5 Biogen Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Autoimmune Therapeutics Drugs Introduction
11.13.4 GlaxoSmithKline Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.13.5 GlaxoSmithKline Recent Development
11.14 Perrigo
11.14.1 Perrigo Company Details
11.14.2 Perrigo Business Overview
11.14.3 Perrigo Autoimmune Therapeutics Drugs Introduction
11.14.4 Perrigo Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.14.5 Perrigo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Therapeutics Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.2.4 Disease-Modifying Anti-Rheumatic Drugs
1.2.5 Monoclonal Antibodies
1.3 Market by Application
1.3.1 Global Autoimmune Therapeutics Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Therapeutics Drugs Market Perspective (2020-2031)
2.2 Global Autoimmune Therapeutics Drugs Growth Trends by Region
2.2.1 Global Autoimmune Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Autoimmune Therapeutics Drugs Historic Market Size by Region (2020-2025)
2.2.3 Autoimmune Therapeutics Drugs Forecasted Market Size by Region (2026-2031)
2.3 Autoimmune Therapeutics Drugs Market Dynamics
2.3.1 Autoimmune Therapeutics Drugs Industry Trends
2.3.2 Autoimmune Therapeutics Drugs Market Drivers
2.3.3 Autoimmune Therapeutics Drugs Market Challenges
2.3.4 Autoimmune Therapeutics Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Therapeutics Drugs Players by Revenue
3.1.1 Global Top Autoimmune Therapeutics Drugs Players by Revenue (2020-2025)
3.1.2 Global Autoimmune Therapeutics Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Autoimmune Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Autoimmune Therapeutics Drugs Revenue
3.4 Global Autoimmune Therapeutics Drugs Market Concentration Ratio
3.4.1 Global Autoimmune Therapeutics Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Therapeutics Drugs Revenue in 2024
3.5 Global Key Players of Autoimmune Therapeutics Drugs Head office and Area Served
3.6 Global Key Players of Autoimmune Therapeutics Drugs, Product and Application
3.7 Global Key Players of Autoimmune Therapeutics Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Therapeutics Drugs Breakdown Data by Type
4.1 Global Autoimmune Therapeutics Drugs Historic Market Size by Type (2020-2025)
4.2 Global Autoimmune Therapeutics Drugs Forecasted Market Size by Type (2026-2031)
5 Autoimmune Therapeutics Drugs Breakdown Data by Application
5.1 Global Autoimmune Therapeutics Drugs Historic Market Size by Application (2020-2025)
5.2 Global Autoimmune Therapeutics Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Autoimmune Therapeutics Drugs Market Size (2020-2031)
6.2 North America Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)
6.4 North America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Therapeutics Drugs Market Size (2020-2031)
7.2 Europe Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)
7.4 Europe Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Therapeutics Drugs Market Size (2020-2031)
8.2 Asia-Pacific Autoimmune Therapeutics Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autoimmune Therapeutics Drugs Market Size (2020-2031)
9.2 Latin America Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)
9.4 Latin America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Therapeutics Drugs Market Size (2020-2031)
10.2 Middle East & Africa Autoimmune Therapeutics Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Autoimmune Therapeutics Drugs Introduction
11.1.4 AbbVie Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Autoimmune Therapeutics Drugs Introduction
11.2.4 Amgen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.2.5 Amgen Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Autoimmune Therapeutics Drugs Introduction
11.3.4 Novartis Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Eli Lilly and Company
11.4.1 Eli Lilly and Company Company Details
11.4.2 Eli Lilly and Company Business Overview
11.4.3 Eli Lilly and Company Autoimmune Therapeutics Drugs Introduction
11.4.4 Eli Lilly and Company Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.4.5 Eli Lilly and Company Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Autoimmune Therapeutics Drugs Introduction
11.5.4 Pfizer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 Roche Holding AG
11.6.1 Roche Holding AG Company Details
11.6.2 Roche Holding AG Business Overview
11.6.3 Roche Holding AG Autoimmune Therapeutics Drugs Introduction
11.6.4 Roche Holding AG Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.6.5 Roche Holding AG Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Autoimmune Therapeutics Drugs Introduction
11.7.4 AstraZeneca Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Autoimmune Therapeutics Drugs Introduction
11.8.4 Abbott Laboratories Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.8.5 Abbott Laboratories Recent Development
11.9 Genentech
11.9.1 Genentech Company Details
11.9.2 Genentech Business Overview
11.9.3 Genentech Autoimmune Therapeutics Drugs Introduction
11.9.4 Genentech Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.9.5 Genentech Recent Development
11.10 Merck & Co.
11.10.1 Merck & Co. Company Details
11.10.2 Merck & Co. Business Overview
11.10.3 Merck & Co. Autoimmune Therapeutics Drugs Introduction
11.10.4 Merck & Co. Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.10.5 Merck & Co. Recent Development
11.11 Bayer
11.11.1 Bayer Company Details
11.11.2 Bayer Business Overview
11.11.3 Bayer Autoimmune Therapeutics Drugs Introduction
11.11.4 Bayer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.11.5 Bayer Recent Development
11.12 Biogen
11.12.1 Biogen Company Details
11.12.2 Biogen Business Overview
11.12.3 Biogen Autoimmune Therapeutics Drugs Introduction
11.12.4 Biogen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.12.5 Biogen Recent Development
11.13 GlaxoSmithKline
11.13.1 GlaxoSmithKline Company Details
11.13.2 GlaxoSmithKline Business Overview
11.13.3 GlaxoSmithKline Autoimmune Therapeutics Drugs Introduction
11.13.4 GlaxoSmithKline Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.13.5 GlaxoSmithKline Recent Development
11.14 Perrigo
11.14.1 Perrigo Company Details
11.14.2 Perrigo Business Overview
11.14.3 Perrigo Autoimmune Therapeutics Drugs Introduction
11.14.4 Perrigo Revenue in Autoimmune Therapeutics Drugs Business (2020-2025)
11.14.5 Perrigo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Autoimmune Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NSAIDs
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Disease-Modifying Anti-Rheumatic Drugs
Table 5. Key Players of Monoclonal Antibodies
Table 6. Global Autoimmune Therapeutics Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Autoimmune Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Autoimmune Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Autoimmune Therapeutics Drugs Market Share by Region (2020-2025)
Table 10. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Autoimmune Therapeutics Drugs Market Share by Region (2026-2031)
Table 12. Autoimmune Therapeutics Drugs Market Trends
Table 13. Autoimmune Therapeutics Drugs Market Drivers
Table 14. Autoimmune Therapeutics Drugs Market Challenges
Table 15. Autoimmune Therapeutics Drugs Market Restraints
Table 16. Global Autoimmune Therapeutics Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Autoimmune Therapeutics Drugs Market Share by Players (2020-2025)
Table 18. Global Top Autoimmune Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Therapeutics Drugs as of 2024)
Table 19. Ranking of Global Top Autoimmune Therapeutics Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Autoimmune Therapeutics Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Autoimmune Therapeutics Drugs, Headquarters and Area Served
Table 22. Global Key Players of Autoimmune Therapeutics Drugs, Product and Application
Table 23. Global Key Players of Autoimmune Therapeutics Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Autoimmune Therapeutics Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Autoimmune Therapeutics Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Autoimmune Therapeutics Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Autoimmune Therapeutics Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Autoimmune Therapeutics Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Autoimmune Therapeutics Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Autoimmune Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. AbbVie Company Details
Table 49. AbbVie Business Overview
Table 50. AbbVie Autoimmune Therapeutics Drugs Product
Table 51. AbbVie Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Amgen Company Details
Table 54. Amgen Business Overview
Table 55. Amgen Autoimmune Therapeutics Drugs Product
Table 56. Amgen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 57. Amgen Recent Development
Table 58. Novartis Company Details
Table 59. Novartis Business Overview
Table 60. Novartis Autoimmune Therapeutics Drugs Product
Table 61. Novartis Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Eli Lilly and Company Company Details
Table 64. Eli Lilly and Company Business Overview
Table 65. Eli Lilly and Company Autoimmune Therapeutics Drugs Product
Table 66. Eli Lilly and Company Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 67. Eli Lilly and Company Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Autoimmune Therapeutics Drugs Product
Table 71. Pfizer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Roche Holding AG Company Details
Table 74. Roche Holding AG Business Overview
Table 75. Roche Holding AG Autoimmune Therapeutics Drugs Product
Table 76. Roche Holding AG Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 77. Roche Holding AG Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Autoimmune Therapeutics Drugs Product
Table 81. AstraZeneca Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Abbott Laboratories Company Details
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Autoimmune Therapeutics Drugs Product
Table 86. Abbott Laboratories Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 87. Abbott Laboratories Recent Development
Table 88. Genentech Company Details
Table 89. Genentech Business Overview
Table 90. Genentech Autoimmune Therapeutics Drugs Product
Table 91. Genentech Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 92. Genentech Recent Development
Table 93. Merck & Co. Company Details
Table 94. Merck & Co. Business Overview
Table 95. Merck & Co. Autoimmune Therapeutics Drugs Product
Table 96. Merck & Co. Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 97. Merck & Co. Recent Development
Table 98. Bayer Company Details
Table 99. Bayer Business Overview
Table 100. Bayer Autoimmune Therapeutics Drugs Product
Table 101. Bayer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 102. Bayer Recent Development
Table 103. Biogen Company Details
Table 104. Biogen Business Overview
Table 105. Biogen Autoimmune Therapeutics Drugs Product
Table 106. Biogen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 107. Biogen Recent Development
Table 108. GlaxoSmithKline Company Details
Table 109. GlaxoSmithKline Business Overview
Table 110. GlaxoSmithKline Autoimmune Therapeutics Drugs Product
Table 111. GlaxoSmithKline Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 112. GlaxoSmithKline Recent Development
Table 113. Perrigo Company Details
Table 114. Perrigo Business Overview
Table 115. Perrigo Autoimmune Therapeutics Drugs Product
Table 116. Perrigo Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 117. Perrigo Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Autoimmune Therapeutics Drugs Picture
Figure 2. Global Autoimmune Therapeutics Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Autoimmune Therapeutics Drugs Market Share by Type: 2024 VS 2031
Figure 4. NSAIDs Features
Figure 5. Corticosteroids Features
Figure 6. Disease-Modifying Anti-Rheumatic Drugs Features
Figure 7. Monoclonal Antibodies Features
Figure 8. Global Autoimmune Therapeutics Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Autoimmune Therapeutics Drugs Market Share by Application: 2024 VS 2031
Figure 10. Hospitals and Clinics Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Autoimmune Therapeutics Drugs Report Years Considered
Figure 14. Global Autoimmune Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Autoimmune Therapeutics Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Autoimmune Therapeutics Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Autoimmune Therapeutics Drugs Market Share by Players in 2024
Figure 18. Global Top Autoimmune Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Therapeutics Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Autoimmune Therapeutics Drugs Revenue in 2024
Figure 20. North America Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)
Figure 22. United States Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)
Figure 26. Germany Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Autoimmune Therapeutics Drugs Market Share by Region (2020-2031)
Figure 34. China Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AbbVie Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 50. Amgen Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 53. Pfizer Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 54. Roche Holding AG Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 55. AstraZeneca Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 56. Abbott Laboratories Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 57. Genentech Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 58. Merck & Co. Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 59. Bayer Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 60. Biogen Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 62. Perrigo Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Autoimmune Therapeutics Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of NSAIDs
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Disease-Modifying Anti-Rheumatic Drugs
Table 5. Key Players of Monoclonal Antibodies
Table 6. Global Autoimmune Therapeutics Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Autoimmune Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Autoimmune Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Autoimmune Therapeutics Drugs Market Share by Region (2020-2025)
Table 10. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Autoimmune Therapeutics Drugs Market Share by Region (2026-2031)
Table 12. Autoimmune Therapeutics Drugs Market Trends
Table 13. Autoimmune Therapeutics Drugs Market Drivers
Table 14. Autoimmune Therapeutics Drugs Market Challenges
Table 15. Autoimmune Therapeutics Drugs Market Restraints
Table 16. Global Autoimmune Therapeutics Drugs Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Autoimmune Therapeutics Drugs Market Share by Players (2020-2025)
Table 18. Global Top Autoimmune Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Therapeutics Drugs as of 2024)
Table 19. Ranking of Global Top Autoimmune Therapeutics Drugs Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Autoimmune Therapeutics Drugs Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Autoimmune Therapeutics Drugs, Headquarters and Area Served
Table 22. Global Key Players of Autoimmune Therapeutics Drugs, Product and Application
Table 23. Global Key Players of Autoimmune Therapeutics Drugs, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Autoimmune Therapeutics Drugs Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Autoimmune Therapeutics Drugs Revenue Market Share by Type (2020-2025)
Table 27. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Autoimmune Therapeutics Drugs Revenue Market Share by Type (2026-2031)
Table 29. Global Autoimmune Therapeutics Drugs Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Autoimmune Therapeutics Drugs Revenue Market Share by Application (2020-2025)
Table 31. Global Autoimmune Therapeutics Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Autoimmune Therapeutics Drugs Revenue Market Share by Application (2026-2031)
Table 33. North America Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Autoimmune Therapeutics Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Autoimmune Therapeutics Drugs Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Autoimmune Therapeutics Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Autoimmune Therapeutics Drugs Market Size by Country (2026-2031) & (US$ Million)
Table 48. AbbVie Company Details
Table 49. AbbVie Business Overview
Table 50. AbbVie Autoimmune Therapeutics Drugs Product
Table 51. AbbVie Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Amgen Company Details
Table 54. Amgen Business Overview
Table 55. Amgen Autoimmune Therapeutics Drugs Product
Table 56. Amgen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 57. Amgen Recent Development
Table 58. Novartis Company Details
Table 59. Novartis Business Overview
Table 60. Novartis Autoimmune Therapeutics Drugs Product
Table 61. Novartis Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Eli Lilly and Company Company Details
Table 64. Eli Lilly and Company Business Overview
Table 65. Eli Lilly and Company Autoimmune Therapeutics Drugs Product
Table 66. Eli Lilly and Company Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 67. Eli Lilly and Company Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Autoimmune Therapeutics Drugs Product
Table 71. Pfizer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. Roche Holding AG Company Details
Table 74. Roche Holding AG Business Overview
Table 75. Roche Holding AG Autoimmune Therapeutics Drugs Product
Table 76. Roche Holding AG Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 77. Roche Holding AG Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Autoimmune Therapeutics Drugs Product
Table 81. AstraZeneca Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Abbott Laboratories Company Details
Table 84. Abbott Laboratories Business Overview
Table 85. Abbott Laboratories Autoimmune Therapeutics Drugs Product
Table 86. Abbott Laboratories Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 87. Abbott Laboratories Recent Development
Table 88. Genentech Company Details
Table 89. Genentech Business Overview
Table 90. Genentech Autoimmune Therapeutics Drugs Product
Table 91. Genentech Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 92. Genentech Recent Development
Table 93. Merck & Co. Company Details
Table 94. Merck & Co. Business Overview
Table 95. Merck & Co. Autoimmune Therapeutics Drugs Product
Table 96. Merck & Co. Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 97. Merck & Co. Recent Development
Table 98. Bayer Company Details
Table 99. Bayer Business Overview
Table 100. Bayer Autoimmune Therapeutics Drugs Product
Table 101. Bayer Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 102. Bayer Recent Development
Table 103. Biogen Company Details
Table 104. Biogen Business Overview
Table 105. Biogen Autoimmune Therapeutics Drugs Product
Table 106. Biogen Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 107. Biogen Recent Development
Table 108. GlaxoSmithKline Company Details
Table 109. GlaxoSmithKline Business Overview
Table 110. GlaxoSmithKline Autoimmune Therapeutics Drugs Product
Table 111. GlaxoSmithKline Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 112. GlaxoSmithKline Recent Development
Table 113. Perrigo Company Details
Table 114. Perrigo Business Overview
Table 115. Perrigo Autoimmune Therapeutics Drugs Product
Table 116. Perrigo Revenue in Autoimmune Therapeutics Drugs Business (2020-2025) & (US$ Million)
Table 117. Perrigo Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Autoimmune Therapeutics Drugs Picture
Figure 2. Global Autoimmune Therapeutics Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Autoimmune Therapeutics Drugs Market Share by Type: 2024 VS 2031
Figure 4. NSAIDs Features
Figure 5. Corticosteroids Features
Figure 6. Disease-Modifying Anti-Rheumatic Drugs Features
Figure 7. Monoclonal Antibodies Features
Figure 8. Global Autoimmune Therapeutics Drugs Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Autoimmune Therapeutics Drugs Market Share by Application: 2024 VS 2031
Figure 10. Hospitals and Clinics Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Online Pharmacies Case Studies
Figure 13. Autoimmune Therapeutics Drugs Report Years Considered
Figure 14. Global Autoimmune Therapeutics Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Autoimmune Therapeutics Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Autoimmune Therapeutics Drugs Market Share by Region: 2024 VS 2031
Figure 17. Global Autoimmune Therapeutics Drugs Market Share by Players in 2024
Figure 18. Global Top Autoimmune Therapeutics Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Therapeutics Drugs as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Autoimmune Therapeutics Drugs Revenue in 2024
Figure 20. North America Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)
Figure 22. United States Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)
Figure 26. Germany Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Autoimmune Therapeutics Drugs Market Share by Region (2020-2031)
Figure 34. China Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)
Figure 42. Mexico Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Autoimmune Therapeutics Drugs Market Share by Country (2020-2031)
Figure 46. Turkey Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Autoimmune Therapeutics Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. AbbVie Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 50. Amgen Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 51. Novartis Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 52. Eli Lilly and Company Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 53. Pfizer Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 54. Roche Holding AG Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 55. AstraZeneca Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 56. Abbott Laboratories Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 57. Genentech Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 58. Merck & Co. Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 59. Bayer Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 60. Biogen Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 62. Perrigo Revenue Growth Rate in Autoimmune Therapeutics Drugs Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232